Comparison of efficacy, safety, patients’ quality of life, and doctors’ occupational stress between lenalidomide‐based and bortezomib‐based induction in patients with newly diagnosed multiple myeloma
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Medicine"
DOI: 10.1002/cam4.3762
Abstract: In the new therapeutic era, comparisons between regimens containing lenalidomide and bortezomib are needed. read more here.
Keywords: efficacy safety; patients quality; quality life; safety patients ... See more keywords